NASDAQ:ENSC | Profit Breakdown | Ensysce Biosciences, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$1.16M-$2.58M-$2.57M
2026-03-31$960,999.00-$3.56M-$3.56M
2025-12-31$1.88M-$2.78M-$2.77M
2025-09-30$493,104.00-$3.74M-$3.73M
2025-06-30$1.37M-$1.75M-$1.73M
2025-03-31$1.32M-$1.97M-$1.95M
2024-12-31$1.3M-$3.58M-$3.56M
2024-09-30$3.42M$644,746.00$661,769.00
2024-06-30$181,797.00-$1.96M-$1.97M
2024-03-31$305,722.00-$1.84M-$3.12M
2023-12-31$515,032.00-$3.16M-$3.5M
2023-09-30$435,380.00-$2.71M-$2.69M
2023-06-30$490,472.00-$2.29M-$2.24M
2023-03-31$789,635.00-$2.56M-$2.19M
2022-12-31$1.43M-$6.2M-$5.48M
2022-09-30$279,351.00-$6.16M-$9.86M
2022-06-30$207,471.00-$7.06M-$7.92M
2022-03-31$603,098.00-$4.8M-$950,925.00
2021-12-31$1.64M-$2.01M-$10.1M
2021-09-30$1.2M-$16.89M-$17.16M
2021-06-30$444,516.00-$412,617.00-$935,544.00
2021-03-31$250,576.00-$524,273.00-$1.77M-$1.71M
2020-12-31$416,489.00-$1.09M-$94,439.00$2.56M
2020-09-30$827,639.00-$404,774.00-$285,414.00$1.57M
2020-06-30$1.82M$139,081.00$3.3M-$704,498.00
2020-03-31-$915,183.00$1.87M$1.79M
2019-12-31-$1.93M-$1.22M-$1.32M
2019-09-30-$584,418.00$504,041.00$489,723.00
2019-06-30-$625,938.00$646,116.00$418,902.00
2019-03-31-$189,174.00$990,269.00$775,913.00
2018-12-31-$229,381.00$904,098.00$723,208.00
2018-09-30-$248,187.00$707,774.00$577,649.00
2018-06-30-$311,538.00$544,896.00$415,110.00
2018-03-31-$170,134.00$519,181.00$406,066.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$5.07M-$10.24M-$10.18M
2024-12-31$5.21M-$6.73M-$7.99M
2023-12-31$2.23M-$10.72M-$10.63M
2022-12-31$2.52M-$24.22M-$24.21M
2021-12-31$3.53M-$19.87M-$29.15M
2020-12-31$3.93M-$1.61M$2.65M$2.4M
2019-12-31-$3.33M$921,154.00$365,954.00
2018-12-31-$959,240.00$2.68M$2.12M